@NotClever4 "Most candidates for which information is available aim to induce neutralizing antibodies against the viral spike (S) protein, preventing uptake via the human ACE2 receptor." That is, they were designed to block infection. https://t.co/mdZXzPq
@Trump2428 @HigherElevated @AshaRangappa_ @SpiroAgnewGhost JANUARY, moron... https://t.co/wFFYbQ2VrZ
RT @MariuszJagora: dostosowane do określonych podgrup populacji (takich jak osoby starsze, dzieci, kobiety w ciąży lub pacjenci z obniżoną…
RT @MariuszJagora: dostosowane do określonych podgrup populacji (takich jak osoby starsze, dzieci, kobiety w ciąży lub pacjenci z obniżoną…
RT @MariuszJagora: dostosowane do określonych podgrup populacji (takich jak osoby starsze, dzieci, kobiety w ciąży lub pacjenci z obniżoną…
dostosowane do określonych podgrup populacji (takich jak osoby starsze, dzieci, kobiety w ciąży lub pacjenci z obniżoną odpornością). Autorzy artykułu w Nature https://t.co/D6NRcqK4P0 zauważają, że nowe platformy oparte na DNA lub mRNA oferują dużą elastyc
@Fernand54339604 @FLicoretas @PedroInsua1 @No_creo_nada Estaban en desarrollo: https://t.co/K7GHR59xj3
@LadyNarrowboat1 Be honest, could you pass a basic 7th grade biology test? Sure, be curious about science and medicine. But don’t pretend like you’re an expert epidemiologist. How much of this article do you understand? https://t.co/sTsOibFOKj
RT @JVParkkinen: Rokotekehitys COVID-19 -tautia vastaan etenee ennennäkemättömän nopeasti: 5 rokotetta kliinisissä tutkimuksissa ja 73 prek…
@justalexandraa pierdolisz https://t.co/Ly7kFZoc4Z
@AndrewHayen Or there’s this.
RT @DeeCee451: @stephenjduckett @inquisitiveGyn @LRussellWolpe Case in point. In April 2020 this expert thought the chances of a vaccine in…
RT @DeeCee451: @stephenjduckett @inquisitiveGyn @LRussellWolpe Case in point. In April 2020 this expert thought the chances of a vaccine in…
@ranjitrao1 @stephenjduckett @inquisitiveGyn @LRussellWolpe Then there’s this from 18 months ago.
RT @DeeCee451: @stephenjduckett @inquisitiveGyn @LRussellWolpe Case in point. In April 2020 this expert thought the chances of a vaccine in…
@stephenjduckett @inquisitiveGyn @LRussellWolpe Case in point. In April 2020 this expert thought the chances of a vaccine in 2021 as being a ‘maybe’.
@lacoleredejesus @cdube_sante @ciusss_csmtl https://t.co/lEKYSIE0ia Bonne lecture, ça va probablement être au dessus de ton niveau habituel
The COVID-19 vaccine development landscape https://t.co/xsRFQcH3X9
@Smarter21905829 @kidney_boy So, I guess you think that the vaccine developers did not understand either: "Most candidates for which information is available aim to induce neutralizing antibodies against the viral spike (S) protein, preventing uptake via t
Pengembangan Vaksin COVID-19: Lanskap pengembangan vaksin COVID-19 https://t.co/KsSY0xlZKy Pandemi 2020: Pengembangan Vaksin SARS-CoV-2 Saat Ini https://t.co/g8JmBB94Ip
@ArchoProbato ”Most candidates for which information is available aim to induce neutralizing antibodies against the viral spike (S) protein, preventing uptake via the human ACE2 receptor.” IOW, most vaccines set out to prevent infection. Now, they often
@AppreciatesNick @londongal_28 @Acyn True that Moderna had a candidate go into testing on March 16 of 2020, and others followed soon after. If we stick to "potential" and not a developed result, it was credible and I confess being too hard on the statement
@sgeekfemale @SheriD17536431 @DrEricDing @patch103 @PressSec @edokeefe From the very beginning, "Most [vaccine] candidates...aim to induce neutralizing antibodies against the viral spike (S) protein, preventing uptake via the human ACE2 receptor." Getting
@mark08292020 @CTVNews This is about as long term as it gets! Nothing in life is 100% ! https://t.co/uzuxzZoliH
@existentialrest @revelation_free @PowerFool515 @mojos55 The publication of pre-peer reviewed papers is not unusual. What is, is that protocols have been altered in response to the necessity of minimising response time. This is worth reading in full. “Out
@megatog615 @theangrudkip @queerBengali I wouldn’t attribute it to the former guy either. Scientists started worked on it back on January of 2020, it is what scientists do. I am thankful for scientists and Biden for executing a good rollout of the vaccin
$INO This is an old article from last year. Thought this part about Latin America was worth mentioning https://t.co/VTk8ODmphH https://t.co/sK8xa2zIxq
Re: your question. 👇 Have you met Mr Greenwald?
@xieish @ggreenwald That's absolute bullcrap. Like, where do you come up with those lies? Once work on vaccines started, which was almost immediately a timeline of one year was projected as a probable optimistic path. From April 2020: https://t.co/j7AxfD
@AndrewDeakin13 @DPJHodges @tomhfh @RoryStewartUK I dont know what medic friends you were talking to but it was common consensus that was a reasonable timeframe due to the number of vaccine candidates.. https://t.co/yt3RhtF6bF
RT @caprellid: @CatPurry9 Which, 'ironically', is about the same length of time ago that mRNA vaccines were emerging as the best technology…
@CatPurry9 Which, 'ironically', is about the same length of time ago that mRNA vaccines were emerging as the best technology against COVID. So, if the Gov had actually 'listened to the science', we'd be there by now. https://t.co/gv0QXa4ypF
RT @simonacvasile: Life will never be the same but a vaccine may help kill the fear and allow us to hug our friends and family again. Happy…
@jesusofbohemia @gavreilly @VirginMediaNews Also, why does it matter that you are an SF member? What is the relevance to this? You are clearly wrong! More peer reviewed studies https://t.co/EMuH2JrFBt There is even a pre print I read in Dec 2019 about the
@Dexter85143495 @lymo40636305 @Rebecca_xigua @DerekCh79978132 @KayceeHeyse @Samheeeeee @Reuters Well, if you want to know when did China published the data, just check it. https://t.co/0JB1msJ5eI
@WaKiNg_ShEePlE_ @TCharundel @WSJ Well, let’s try this then, I hope you like this one better than the video. https://t.co/0JB1msJ5eI
Polecam dotyczące szczepionki Na Covid, rzetelne źródła nie żadne https://t.co/hSAOIG8jpI
czuje ogromną satysfakcję, bo zostały użyte artykuły naukowe z prawdziwego zdarzenia ♥️
@jennysmith2017 @DocJeffD @aetiology No. He's a naval vet and he was sincere. And, here's the actual array of tech. He's not that far off and as scientists we should aim to educate those around us but I think we're all tired d/t so many troublemakers -don'
@kevinpurcell @aetiology I think he already is. I haven't looked at the tech for the other non mRNA vaccines. right sorta. https://t.co/ERCunCsxkL
RT @tesfayeous: ARTYKUŁY: 1. https://t.co/c5QGjheZ5l 2. https://t.co/Vkj616HsLr 3. https://t.co/NmVEGctbZy 4. https://t.co/xhafUWwSdr 5. h…
@mloe68 @NPR Here is an article in Nature from April. It may answer some of your questions. https://t.co/C1lFhlgdYF
@rivkasa246 @danielgrupel @ShovalRonen מה שהוא כתב הוא תוצר של השכלה, של ידע ונסיון. כאשר לקחת אקמול, גם אז ביקשת מהרופא אסמכתאות לבטיחות ויעילות? כאשר חוסנת לשפעת? או HPV? רוצה לוודא? הכל נמצא כאן: ללא מתווכים, ללא פילטרים, את לא צריכה אותי, אותו או כל
This link discusses details most mainstream media ignores https://t.co/8ozCwGviYd
@pawwoj1 @TomaszUrbas Pierwsze z brzegu: (polecam Googla - jest mnóstwo informacji w ang.) https://t.co/3uELZcydDk
Never felt impostor syndrome so much as announcing my involvement in this paper! https://t.co/cDGcKRWBT9
RT @una_maria_mas__: fuentes y lecturas chidas pa´quien quiera saber más: https://t.co/Fq89Z00DWj https://t.co/HZaOO4ohKv https://t.co/JVH…
fuentes y lecturas chidas pa´quien quiera saber más: https://t.co/Fq89Z00DWj https://t.co/HZaOO4ohKv https://t.co/JVHX6dw0j4 https://t.co/GR8magfgDN https://t.co/hSvHOzzNB6
@LucaSardo14 No, non conosci i fatti. Virus isolato molte volte nel mondo da 1/2020 https://t.co/jI6bXVX2Dv Tecnologia mRNA: https://t.co/u7bdHVDSLQ https://t.co/SKJu00gjqh https://t.co/NpUXJdIZYu Sul ruolo di CEPI qui https://t.co/P4RwNEPZVp Non ci sia
COVID umbrella trials multiply https://t.co/GFDB9Hk2Cp the trials: RECOVERY, SOLIDARITY, ACTT, PRINCIPLE, REMAP-CAP, ACCORD, and ACTIV... and 115 vaccines in development https://t.co/1WRWIajgFB https://t.co/UGVDg8A4U7
RT @joseramosvivas: 321 #vacunas !Tiene que funcionar! 👇💉 https://t.co/480C5VIv9S https://t.co/IoTSjh7K6R
RT @joseramosvivas: 321 #vacunas !Tiene que funcionar! 👇💉 https://t.co/480C5VIv9S https://t.co/IoTSjh7K6R
There are 321 confirmed #Covid_19 vaccine candidates, 32 of which have already entered #clinicaltrials💉💊 The article in #nature shows a brief overview of the global landscape of #Covid_19 #vaccinedevelopment activity. 👩⚕️😷 Link: https://t.co/7DaXLk228L
RT @joseramosvivas: 321 #vacunas !Tiene que funcionar! 👇💉 https://t.co/480C5VIv9S https://t.co/IoTSjh7K6R
RT @joseramosvivas: 321 #vacunas !Tiene que funcionar! 👇💉 https://t.co/480C5VIv9S https://t.co/IoTSjh7K6R
321 #vacunas !Tiene que funcionar! 👇💉 https://t.co/480C5VIv9S https://t.co/IoTSjh7K6R
@canteach She can find numerous comparison articles on the internet as to the different types and manufacturers of vaccine globally, what stages they're at, etc. She should look for medical or scientific journal articles that are not touting one over anoth
@Lesmitch529 There are some ways that the process has been accelerated, and you can get a brief overview if you scroll down to "Outlook" on this article: https://t.co/Tqraa1Rbrf
The COVID-19 vaccine development landscape https://t.co/BHm2FjkILy
@LH @CT_Bergstrom @mbeisen I’m sure you have seen this synopsis...since you LITERALLY are the worlds expert. To be fair, my specialty is research on the device side of lung cancer treatment, not in vaccine dev..but I can ask the scientists DOWN THE HALL if
@CLE_CMA From @nature ; also confirming mRNA 1273 has no HEK 293 involvement. Given the genome of COVID 19, it’s entirely possible to artificially produce such w/out unethical sourcing. Link https://t.co/2zub1cD0SP Many sources have misleadingly affirme
¿Cuándo estará disponible una vacuna? Aquí un panorama que si bien no es muy alentador, es real y no es una cadena de WhatsApp. https://t.co/eptx3vK0vp
RT @oatila: Pra quem perguntou sobre vacinas, a Nature soltou uma compilação ótima sobre iniciativas em andamento: https://t.co/8jYrc1fMkq…
RT @Tejen02657624: The COVID-19 vaccine development landscape https://t.co/5oaySFIP3D
The COVID-19 vaccine development landscape https://t.co/hIMKbnhzsq
The #COVID19vaccine development landscape https://t.co/4Z73dGqG83 | via @NatRevDrugDisc
RT @CyHusain: @trishie818 @CABiotech Those studies have been going on for some time now if you want to look through some Medical Journals!…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @JonathanHeeney: DIOSynVax’s #SARSCoV2 vaccine strategy is on target to broaden vaccine antigen responses https://t.co/35dv7xictD
@sabrinabiagi3 @CABiotech With a little research you can find them published even sooner! https://t.co/4qnpPN4005
@trishie818 @CABiotech Those studies have been going on for some time now if you want to look through some Medical Journals! https://t.co/4qnpPN4005
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @Cardenas_JorgeH: Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista N…
RT @JeremyFarrar: Summary early April vaccine R&D SARS-CoV-2. Progress since as these & others into clinical trials. Need to broaden target…
#NIHRLearn The COVID-19 vaccine development landscape https://t.co/n4KD3WES2i
Son 115 buenas razones para la esperanza. Es el total de vacunas en desarrollo para el COVID, que reporta la revista Nature. 78 fueron confirmadas y 37 no son confirmadas, todas en la revista. https://t.co/IhQxXzeYrq https://t.co/UGwJ4HtLCo
RT @JeremyFarrar: Summary early April vaccine R&D SARS-CoV-2. Progress since as these & others into clinical trials. Need to broaden target…
Key update from #JeremyFarrar w overview of superhuman vaccine efforts across the world: urgent need to diversify and broaden target of vaccines from spike protein...#COVID__19
DIOSynVax’s #SARSCoV2 vaccine strategy is on target to broaden vaccine antigen responses
@oatila Inclusive essa publicação na mesma revista científica comenta sobre a possibilidade de termos uma vacina eficiente em tempo recorde e os avanços das principais que estão em pesquisa. Mas esse tipo de estudo ele não comenta. Não acho que seja por ac
RT @JeremyFarrar: Summary early April vaccine R&D SARS-CoV-2. Progress since as these & others into clinical trials. Need to broaden target…